Clover Health Investments Corp.

14.66-0.3700-2.46%Vol 95.93M1Y Perf 43.33%
Jun 14th, 2021 16:00 DELAYED
BID14.56 ASK14.59
Open14.65 Previous Close15.03
Pre-Market- After-Market-
 - -  - -%
Target Price
14.67 
Analyst Rating
— — 0.00
Potential %
0.07 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+ —    58.29
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+ —    50.68
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap5.98B 
Earnings Rating
Price Range Ratio 52W %
37.05 
Earnings Date
17th May 2021

Today's Price Range

13.6016.05

52W Range

6.3128.85

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-33.81%
1 Month
96.25%
3 Months
65.18%
6 Months
32.67%
1 Year
43.33%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CLOV14.66-0.3700-2.46
AAPL130.483.13002.46
GOOG2 527.0413.11000.52
MSFT259.892.00000.78
XOM62.07-0.1000-0.16
WFC45.15-0.5300-1.16
JNJ165.370.41000.25
FB336.775.51001.66
GE13.47-0.2200-1.61
JPM157.57-2.7200-1.70
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.12-0.13-8.33
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.12
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume95.93M
Shares Outstanding408.10M
Trades Count381.17K
Dollar Volume143.12M
Avg. Volume34.90M
Avg. Weekly Volume299.54M
Avg. Monthly Volume93.86M
Avg. Quarterly Volume46.94M

Clover Health Investments Corp. (NASDAQ: CLOV) stock closed at 14.66 per share at the end of the most recent trading day (a -2.46% change compared to the prior day closing price) with a volume of 96.42M shares and market capitalization of 5.98B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 458 people. Clover Health Investments Corp. CEO is Vivek Garipalli.

The one-year performance of Clover Health Investments Corp. stock is 43.33%, while year-to-date (YTD) performance is -12.58%. CLOV stock has a five-year performance of %. Its 52-week range is between 6.31 and 28.85, which gives CLOV stock a 52-week price range ratio of 37.05%

Clover Health Investments Corp. currently has a PE ratio of -141.70, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of 185.54, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -3.11%, a ROC of -4.21% and a ROE of -4.62%. The company’s profit margin is -77.54%, its EBITDA margin is -74.10%, and its revenue ttm is $34.82 Million , which makes it $0.08 revenue per share.

Of the last four earnings reports from Clover Health Investments Corp., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Clover Health Investments Corp.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Clover Health Investments Corp. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Clover Health Investments Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Clover Health Investments Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Clover Health Investments Corp. has a Buy technical analysis rating based on Technical Indicators (ADX : 47.09, ATR14 : 2.67, CCI20 : 82.21, Chaikin Money Flow : -0.07, MACD : 2.01, Money Flow Index : 56.55, ROC : 100.00, RSI : 60.27, STOCH (14,3) : 35.29, STOCH RSI : 0.01, UO : 43.27, Williams %R : -64.71), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Clover Health Investments Corp. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.

CEO: Vivek Garipalli

Telephone: +1 201 432-2133

Address: 725 Cool Springs Boulevard, Franklin 37067, TN, US

Number of employees: 458

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

56%44%

Bearish Bullish

56%44%

Bearish Bullish

67%33%

News

Stocktwits